First Combined-Company Quarter: $885K Revenue, Positive Net Income, Equity Turns Positive
LQWC has more than doubled off its 52-week low of $0.001 on light trading volume (0.3× avg).
Summary
LifeQuest filed its first quarterly report as a combined company after the June 12, 2026 acquisitions of CARE and CFSI, and the numbers are a step change from a development-stage story. Revenue came in at $885,400 versus zero a year earlier, with gross margin of about 64% and pretax income of $24,249 against a prior-year loss of $(56,300). The balance sheet flipped: stockholders' equity is now $519,104 versus a $(158,854) deficit at fiscal year-end, working capital is positive at $397,302, and cash rose to $548,200 from $187,320 at May 31, 2026. Deferred revenue of $935,226 is the number to focus on — it is billed or received cash not yet recognized, and management says BioPipe books revenue only at plant handover. Debt is minimal: $100,000 principal across an $85,000 promissory note and a $15,000 convertible note, with no long-term debt. The stated next step is a PCAOB audit and SEC registration (Form 10 or S-1) plus an OTCQB application, which is what would let a broader investor base value the company; the financials are unaudited and not reviewed or compiled.
At the time of this announcement, LQWC was trading at $0.01 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $1.7M. The 52-week trading range was $0.00 to $0.02. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: EQS.